Neonatal pharmacology-pharmacokinetics

Neonatal Network

Volumn 30, Issue 1, 2011, Pages 54-61

  Johnson, Patricia J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE TO HEALTH; CHILD DEVELOPMENT; DRUG EFFECT; EVIDENCE BASED MEDICINE; HUMAN; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; NEWBORN NURSING; NURSING; ORGANIZATION AND MANAGEMENT; PHARMACOKINETICS; PRACTICE GUIDELINE; PREMATURITY; REVIEW;

CHILD DEVELOPMENT; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; NEONATAL NURSING; PHARMACOKINETICS; PRACTICE GUIDELINES AS TOPIC;

EID: 79958834743     PISSN: 07300832     EISSN: 15392880     Source Type: Journal    
DOI: 10.1891/0730-0832.30.1.54     Document Type: Article

References (14)

1. Alcorn, J., & McNamara, P. (2003). Pharmacokinetics in the newborn. Advanced Drug Delivery Reviews, 55, 667-686.
2. Reiter, P. D. (2002, November). Neonatal pharmacology and pharmacokinetics. Retrieved from http://neoreviews.aappublications. org/cgi/content/full/neoreviews:3/11/e229
3. Tetelbaum, M., Finkelstein, Y., Nava-Ocampo, A., & Koren, G. (2005). Back to basics: Understanding drugs in children: Pharmacokinetic maturation. Pediatrics in Review, 26, 321-328.
4. Skinner, A. (2008). Neonatal pharmacology. Anaesthesia and Intensive Care Medicine, 9, 99-103.
5. Blumer, J., & Reed, M. (2005). Principles of neonatal pharmacology. In S. Yaffe & J. Aranda (Eds.), Neonatal and pediatric pharmacology: Therapeutic principles in practice (3rd ed., pp. 146-156). Philadephia: Lippincott Williams & Wilkins.
6. Warner, A. (1986). Drug use in the neonate: Interrelationships of pharmacokinetics, toxicity, and biochemical maturity. Clinical Chemistry, 32, 721-727.
7. Borchard, U. (1990). Pharmacokinetics of beta-adrenoceptor blocking agents: Clinical significance of hepatic and/or renal clearance. Clinical Physiology & Biochemistry, 8 (Suppl. 2), 28-34.
8. Lugo, R., & Ward, R. (2004). Basic pharmacokinetic principles. In R. Polin, W. Fox, & S. Abman (Eds.), Fetal and neonatal physiology (3rd ed., pp. 190-197). Philadephia: Harcourt Health Sciences.
9. Ward, R. M., Lane, R. H., & Albertine, K. H. (2006). Basic and translational research in neonatal pharmacology. Journal of Perinatology, 26, S8-S12.
10. Allegaert, K., van den Anker, J., Naulaers, G., & de Hoon, J. (2007). Determinants of drug metabolism in early neonatal life. Current Clinical Pharmacology, 2, 23-29.
11. Blake, M., Castro, L., Leeder, J., & Kearns, G. (2005). Ontogeny of drug metabolizing enzymes in the neonate. Seminars in Fetal & Neonatal Medicine, 10, 123-138.
12. Ward, R. (1998). Pharmacologic principles and practicalities. In H. Taeusch & R. Ballard (Eds.), Avery's diseases of the newborn (pp. 404-412). Philadephia: W.B. Saunders.
13. Holford, N. (2009). Pharmacokinetics and pharmacodynamics: Rational dosing and the time course of drug action. In B. Katzung, S. Masters, & A. Trevor (Eds.), Basic and clinical pharmacology (11th ed., pp. 37-52). New York: McGraw-Hill.
14. Allegaert, K., Verbesselt, R., Naulaers, G., van den Anker, J., Rayyan, M., Debeer, A., & de Hoon, J. (2008). Developmental pharmacology: Neonates are not just small adults. Acta Clinica Belgica, 63, 16-24.